1-20 of 92
Anna Azvolinsky, PhD
Close
Sort by
News

Daratumumab Plus Lenalidomide Combination Improves Conversion to MRD-Negative Status in Post-Transplant Patients With Multiple Myeloma

Anna Azvolinsky, PhD
Published: 2024
Abstract
January 2025
View News titled, Daratumumab Plus Lenalidomide Combination Improves Conversion to MRD-Negative Status in Post-Transplant Patients With Multiple Myeloma
News

Discontinuing Maintenance Therapy for Multiple Myeloma Is Feasible, New Study Shows

Anna Azvolinsky, PhD
Published: 2024
Abstract
December 2024
View News titled, Discontinuing Maintenance Therapy for Multiple Myeloma Is Feasible, New Study Shows
News

ASH Recruitment Program Boosts Representation in Hematology Field, Study Shows

Anna Azvolinsky, PhD
Published: 2024
Abstract
December 2024
View News titled, ASH Recruitment Program Boosts Representation in Hematology Field, Study Shows
News

Bispecific T-Cell Engager Results in CR, Clears MRD in Patients with R/R Follicular Lymphoma

Anna Azvolinsky, PhD
Published: 2024
Abstract
January 2025
View News titled, Bispecific T-Cell Engager Results in CR, Clears MRD in Patients with R/R Follicular Lymphoma
News

Quadruple Combination with Brentuximab Vedotin, Nivolumab Continues to Show Strong Efficacy in Early-Stage cHL

Anna Azvolinsky, PhD
Published: 2024
Abstract
January 2025
View News titled, Quadruple Combination with Brentuximab Vedotin, Nivolumab Continues to Show Strong Efficacy in Early-Stage cHL
News

Bispecific Antibody Elicits High Responses Among Patients With Heavily Pretreated CLL

Anna Azvolinsky, PhD
Published: 2024
Abstract
January 2025
View News titled, Bispecific Antibody Elicits High Responses Among Patients With Heavily Pretreated CLL
News

MRD-Guided Therapy Improves Quality of Life for Patients With CLL

Anna Azvolinsky, PhD
Published: 2024
Abstract
January 2025
View News titled, MRD-Guided Therapy Improves Quality of Life for Patients With CLL
News

Venetoclax Plus Obinutuzumab a Viable Option for Newly Diagnosed CLL

Anna Azvolinsky, PhD
Published: 2024
Abstract
December Supplement 2024
View News titled, Venetoclax Plus Obinutuzumab a Viable Option for Newly Diagnosed CLL
News

Long-Lasting, Deep Remissions Seen in R/R CLL with Triple Combination Therapy

Anna Azvolinsky, PhD
Published: 2024
Abstract
December Supplement 2024
View News titled, Long-Lasting, Deep Remissions Seen in R/R CLL with Triple Combination Therapy
News

Stem Cell Boost Appears to Be Effective in Treating ICAHT Associated With BCMA-Directed CAR T-Cell Therapy for MM

Anna Azvolinsky, PhD
Published: 2024
Abstract
January 2025
View News titled, Stem Cell Boost Appears to Be Effective in Treating ICAHT Associated With BCMA-Directed CAR T-Cell Therapy for MM
News

Counseling an Effective, Underused Communication Tool to Discuss Reproductive Needs with Female Patients of Childbearing Age With Cancer

Anna Azvolinsky, PhD
Published: 2024
Abstract
January 2025
View News titled, Counseling an Effective, Underused Communication Tool to Discuss Reproductive Needs with Female Patients of Childbearing Age With Cancer
News

Significant Proportion of Cancer Trials Exclude Individuals with Duffy Null–Associated Neutrophil Count, Study Finds

Anna Azvolinsky, PhD
Published: 2024
Abstract
December 2024
View News titled, Significant Proportion of Cancer Trials Exclude Individuals with Duffy Null–Associated Neutrophil Count, Study Finds
News

Experts Release Guidance on Liver-Related Toxicities With Gene Therapy for Hemophilia A

Anna Azvolinsky, PhD
Published: 2024
Abstract
Mid-November 2024
View News titled, Experts Release Guidance on Liver-Related Toxicities With Gene Therapy for Hemophilia A
News

Experts to Discuss Whether to Treat Smoldering Multiple Myeloma

Anna Azvolinsky, PhD
Published: 2024
Abstract
Mid-November 2024
View News titled, Experts to Discuss Whether to Treat Smoldering Multiple Myeloma
News

New Therapy May Be Effective for Patients With Cold Agglutinin Disease, Warm Antibody Autoimmune Hemolytic Anemia

Anna Azvolinsky, PhD
Published: 2024
Abstract
December 2024
View News titled, New Therapy May Be Effective for Patients With Cold Agglutinin Disease, Warm Antibody Autoimmune Hemolytic Anemia
News

Genetics-Based Risk Model to Stratify Survival Outcomes of Patients With AML Treated With Venetoclax-Azacitidine

Anna Azvolinsky, PhD
Published: 2024
Abstract
November 2024
View News titled, Genetics-Based Risk Model to Stratify Survival Outcomes of Patients With AML Treated With Venetoclax-Azacitidine
News

Large Study Compares Serum Thrombopoietin Levels in Pediatric Patients With Acquired Aplastic Anemia, Immune Thrombocytopenia

Anna Azvolinsky, PhD
Published: 2024
Abstract
November 2024
View News titled, Large Study Compares Serum Thrombopoietin Levels in Pediatric Patients With Acquired Aplastic Anemia, Immune Thrombocytopenia
News

Forging a New Standard of Care for Hairy Cell Leukemia

Anna Azvolinsky, PhD
Published: 2024
Abstract
October 2024
View News titled, Forging a New Standard of Care for Hairy Cell Leukemia
News

LBCL Treated With CAR-T Therapy Can Have Durable Responses to Subsequent CAR-T Treatment

Anna Azvolinsky, PhD
Published: 2024
Abstract
October 2024
View News titled, LBCL Treated With CAR-T Therapy Can Have Durable Responses to Subsequent CAR-T Treatment
News

Teclistamab Elicits Responses in Patients With Multiple Myeloma Previously Treated With BCMA-Targeted Therapy

Anna Azvolinsky, PhD
Published: 2024
Abstract
October 2024
View News titled, Teclistamab Elicits Responses in Patients With Multiple Myeloma Previously Treated With BCMA-Targeted Therapy